Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
6.06
-0.11 (-1.78%)
At close: Aug 27, 2026, 4:00 PM EDT
6.03
-0.03 (-0.50%)
After-hours: Aug 27, 2026, 7:48 PM EDT
Sionna Therapeutics Market Cap
Sionna Therapeutics has a market cap or net worth of $273.99 million as of August 27, 2026. Its market cap has decreased by -75.39% in one year.
Market Cap
273.99M
Enterprise Value
13.80M
1-Year Change
-75.39%
Ranking
Category
Stock Price
$6.06
ChartMarket Cap Chart
Since the IPO on February 7, 2025, Sionna Therapeutics's market cap has decreased from $733.61M to $273.99M, a decrease of -62.65%. That is a compound annual growth rate of -47.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 273.99M | -85.08% |
| Dec 31, 2025 | 1.84B | 150.27% |
| Feb 7, 2025 | 733.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 286.86M |
| AC Immune | 283.37M |
| Lineage Cell Therapeutics | 283.26M |
| Surrozen | 278.68M |
| Pyxis Oncology | 278.58M |
| Whitehawk Therapeutics | 275.92M |
| Alector | 274.68M |
| ALX Oncology Holdings | 273.79M |